-
Health & Wellness
Richard Bold, M.D., named site director, Mayo Clinic Comprehensive Cancer Center in Arizona
Share this:
ROCHESTER, Minn. — Richard Bold, M.D., has been named site director of Mayo Clinic Comprehensive Cancer Center in Arizona. Dr. Bold joins Mayo Clinic from the University of California, Davis (UC Davis), where he has built an impressive career marked by excellence in patient care, innovative research and dynamic leadership. While at UC Davis, he served as associate clinical strategy officer, UC Davis Health; physician in chief, UC Davis Comprehensive Cancer Center; executive vice chair, Department of Surgery; professor, Division of Surgical Oncology; medical director, UC Davis Cancer Care Network; and the Isabelle J. McDonald Endowed Professor of Cancer Research.
"Mayo Clinic and Mayo Clinic Comprehensive Cancer Center are thrilled to have recruited Dr. Bold to this critical leadership role at Mayo Clinic in Arizona, and we are excited to work with him to continue to enhance cancer research, education and patient care in the Southwest and across the nation," says Cheryl Willman, M.D., Stephen and Barbara Slaggie Enterprise Executive Director, Mayo Clinic Cancer Programs and Director, Mayo Clinic Comprehensive Cancer Center. "His track record of visionary leadership and dedication to patient-centric healthcare make him an exceptional choice to lead Mayo Clinic Comprehensive Cancer Center in Arizona."
Throughout his career, Dr. Bold has demonstrated a commitment to improving cancer detection and intervention. His passion for bringing leading expertise to each patient, with research and education that deliver innovation, aligns seamlessly with Mayo Clinic's mission and values, making him an ideal fit for this role.
"As we embark on this new chapter with Dr. Bold at the helm, we are confident that his vision and expertise will lead Mayo Clinic Comprehensive Cancer Center in Arizona to even greater heights of excellence," says Richard Gray, M.D., CEO, Mayo Clinic in Arizona. "His dedication to fostering collaboration, nurturing talent and driving innovation will undoubtedly inspire our teams to continue delivering the highest quality cancer care to our patients and community."
Dr. Bold will begin his new role on Oct. 2. He succeeds Alan Bryce, M.D., prior chair of the Division of Hematology/Oncology and interim site director of Mayo Clinic Comprehensive Cancer Center in Arizona.
Mayo Clinic was recently ranked the No. 1 hospital in Arizona and the No. 1 cancer hospital in Arizona by U.S. News & World Report. With tremendous growth in Arizona, Mayo Clinic plans to add more biomanufacturing capabilities and next-generation diagnostics through Discovery Oasis collaborations in the coming years. These advancements will accelerate transformation and foster innovation to create the patient-centered future of healthcare.
Related Articles
